Core Scientific's shareholders voted down a proposed $9 billion sale of the company, a decision that signals growing confidence in a separate partnership with AMD. The rejection, confirmed by the company, clears the way for the two firms to deepen their work on AI infrastructure without the distraction of an ownership change.
Why the Sale Fell Through
The all-cash offer, which would have handed the bitcoin mining and hosting firm to an undisclosed buyer, failed to win enough support from investors. People familiar with the vote said the board had negotiated the deal in good faith, but shareholders ultimately balked at the price tag and the timing. The sale's collapse was not a surprise to those tracking the company's recent moves — the AMD alliance had already shifted the calculus for many long-term holders.
Core Scientific did not disclose the exact vote tally, only that the proposal did not receive the required majority. The company's leadership had previously described the sale as a way to unlock value, but the rejection leaves that strategy on the shelf.
The AMD Partnership's Strategic Weight
At the heart of the shareholder resistance is a collaboration with AMD that the company calls central to its future. The partnership, which involves deploying AMD's chips in data centers, gives Core Scientific a degree of strategic autonomy that a sale would have compromised. Instead of being folded into a larger conglomerate, the firm keeps control of its own roadmap — a point that resonated with investors who see AI workloads as the next growth driver.
The tie-up positions Core Scientific to expand beyond its bitcoin mining roots. AMD's processors are designed for high-performance computing and machine learning, and the company has been pushing into the AI accelerator market. For Core Scientific, that means the potential to host and operate AI infrastructure for third-party clients, a business line that could diversify revenue and reduce reliance on crypto prices.
What Shareholders Saw
The rejection suggests that shareholders believed the partnership's long-term benefits outweighed the immediate payoff of a sale. A sale at $9 billion would have handed investors a clean exit, but it would also have ended their participation in any upside from AI infrastructure. The vote indicates that a majority of voters wanted to stay in the game.
Core Scientific's board had argued that the sale price represented a premium to the company's trading value, but the AMD deal appears to have changed the narrative. Investors were willing to bet that the combined value of the mining business and the AI opportunity exceeds what a buyer was offering.
With the sale off the table, Core Scientific now has to deliver on the promise of the AMD partnership. The company has not announced a timeline for expanding its AI infrastructure, but it has signaled that the work is already underway. The next test will come in the coming quarters, when investors will be looking for evidence that the collaboration is generating revenue and not just headlines.
The company's next earnings report, expected in the fall, will be the first real checkpoint. If the AMD-driven AI business shows tangible progress, the decision to reject the sale will look prescient. If it stalls, shareholders may have traded a guaranteed payout for a gamble that hasn't paid off.
